Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Pro

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Current Oncology Reports|April 17, 2020
Therapy of Peripheral T Cell Lymphoma: Focus on Nodal SubtypesPamela B Allen, Barbara Pro
Expert Opinion on Biological Therapy|September 4, 2012
Brentuximab vedotin in Hodgkin's lymphomaBarbara Pro, Guilherme Fleury Perini
Clinical Lymphoma, Myeloma & Leukemia|April 22, 2026
SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging QuestionsSeda S Tolu, Barbara Pro
Blood|August 4, 2023
How I treat posttransplant lymphoproliferative disorderJennifer E Amengual, Barbara Pro
Expert Review of Hematology|November 19, 2010
Hepatosplenic T-cell lymphoma and TNF-α inhibitorsJenny Vu Pozadzides, Barbara Pro
Expert Review of Hematology|February 5, 2013
Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphomaAlan P Skarbnik, Barbara Pro
Biologics in Therapy|January 7, 2014
Brentuximab Vedotin in CD30+ LymphomasGuilherme Fleury Perini, Barbara Pro
Blood|February 8, 2006
Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphomaAnas Younes, Barbara Pro, Luis Fayad
Seminars in Hematology|April 28, 2021
Management of ALCL and other CD30+ peripheral T-cell lymphomas with a focus on Brentuximab vedotinImran Nizamuddin, Carlos Galvez, Barbara Pro
Current Hematology Reports|July 13, 2005
The lymphomas: molecular pathways and novel therapeutic targetsAmanda Wedgwood, Barbara Pro, Anas Younes
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Current Oncology Reports|April 17, 2020
Therapy of Peripheral T Cell Lymphoma: Focus on Nodal SubtypesPamela B Allen, Barbara Pro
Expert Opinion on Biological Therapy|September 4, 2012
Brentuximab vedotin in Hodgkin's lymphomaBarbara Pro, Guilherme Fleury Perini
Clinical Lymphoma, Myeloma & Leukemia|April 22, 2026
SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging QuestionsSeda S Tolu, Barbara Pro
Blood|August 4, 2023
How I treat posttransplant lymphoproliferative disorderJennifer E Amengual, Barbara Pro
Expert Review of Hematology|November 19, 2010
Hepatosplenic T-cell lymphoma and TNF-α inhibitorsJenny Vu Pozadzides, Barbara Pro
Expert Review of Hematology|February 5, 2013
Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphomaAlan P Skarbnik, Barbara Pro
Biologics in Therapy|January 7, 2014
Brentuximab Vedotin in CD30+ LymphomasGuilherme Fleury Perini, Barbara Pro
Blood|February 8, 2006
Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphomaAnas Younes, Barbara Pro, Luis Fayad
Seminars in Hematology|April 28, 2021
Management of ALCL and other CD30+ peripheral T-cell lymphomas with a focus on Brentuximab vedotinImran Nizamuddin, Carlos Galvez, Barbara Pro
Current Hematology Reports|July 13, 2005
The lymphomas: molecular pathways and novel therapeutic targetsAmanda Wedgwood, Barbara Pro, Anas Younes
Pageof 19